Skip to content

Integra LifeSciences IART Tissue Reconstruction — Total Revenues

Other segment segments

Specialty Surgery
$283.14M

Similar metrics at other companies

Artivion logo
AORTProducts — Total revenues
$91.44M+16.0%
Enovis logo
ENOVReconstructive — Net Sales
$317.13M+10.8%
Bausch + Lomb logo
BLCOSurgical — Total revenues
$228M+6.5%
Asset Entities logo
ASSTMedical Device — Total revenues
$1.37M
Artivion logo
AORTMedical devices — Total revenues
$91.44M+16.0%
Mirion Technologies logo
MIRMedical Segment — Total revenues
$72.1M+5.1%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's tissue reconstruction — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's tissue reconstruction — total revenues?
Integra LifeSciences (IART) reported tissue reconstruction — total revenues of $108.78M in Q1 2026.
What does tissue reconstruction — total revenues mean?
This represents the total gross sales generated by the Tissue Reconstruction business segment. It serves as a primary indicator of market demand and the segment's contribution to the company's overall top-line growth.